Literature DB >> 6179470

Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues.

B Eriksson, G Stening, B Oberg.   

Abstract

Several pyrophosphate analogues have been studied for their effects on avian myeloblastosis virus reverse transcriptase and on cellular DNA polymerase alpha. Examination of structure-activity relationships for these compounds revealed that two acidic groups connected by a short bridge were necessary, but not sufficient, for inhibition of the enzyme activities. Foscarnet sodium (trisodium phosphonoformate) was the most potent inhibitor of reverse transcriptase, giving non-competitive inhibition of reactions primed by (rA)n . (dT)12-18, (rC)n . (dG)12-18, (dC)n . (dG)12-18, and activated DNA. Carbonyldiphosphonate and 2-hydroxyphosphonoacetate also caused non-competitive inhibition patterns, whereas hypophosphate and imidodiphosphonate inhibited AMV reverse transcriptase in a competitive, non-linear manner. The reverse transcriptase reactions directed by (rA)n . (dT)12-18 and activated DNA were most affected by the non-competitive inhibitors. Hypophosphate and imidodiphosphonate inhibited preferentially reactions primed by (dC)n . (dG)12-18 and activated DNA. In all cases the (rC)n . (dG)12-18 directed reaction was the least affected.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179470     DOI: 10.1016/0166-3542(82)90028-6

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase.

Authors:  L Vrang; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Different patterns of inhibition of avian myeloblastosis virus reverse transcriptase activity by 3'-azido-3'-deoxythymidine 5'-triphosphate and its threo isomer.

Authors:  B Eriksson; L Vrang; H Bazin; J Chattopadhyaya; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.

Authors:  B F Eriksson; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 4.  Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.

Authors:  C U Tuazon; A M Labriola
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

5.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.